WallStreetZenWallStreetZen

NASDAQ: DXCM
Dexcom Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DXCM past earnings growth

How has DXCM's earnings growth performed historically?
Company
55%
Industry
-2.43%
Market
36.61%
DXCM's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DXCM's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DXCM's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DXCM past revenue growth

How has DXCM's revenue growth performed historically?
Company
19.61%
Industry
5.82%
Market
13.73%
DXCM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DXCM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DXCM's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DXCM earnings and revenue history

Current Revenue
$3.2B
Current Earnings
$357.5M
Current Profit Margin
11.2%

DXCM Return on Equity

Current Company
17.3%
Current Industry
7.1%
Current Market
22.1%
DXCM's Return on Equity (17.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DXCM announces earnings.

DXCM Return on Assets

Current Company
6.3%
Current Industry
4.4%
DXCM is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DXCM Return on Capital Employed

Current Company
10.21%
Current Industry
7.5%
DXCM has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DXCM vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DXCM$3.20B$646.10M$357.50M+30.88%+87.49%
EW$5.66B$1.79B$1.39B+9.78%+16.83%
ZBH$7.20B$1.78B$505.60M-1.87%-22.07%
ALGN$3.74B$712.68M$314.09M+16.60%+2.04%
STE$5.09B$850.42M$119.32M+13.92%-19.50%
View Top Medical Device Stocks

DXCM earnings dates

Next earnings date
Oct 25, 2023

Dexcom Earnings & Revenue FAQ

What were DXCM's earnings last quarter?

On Invalid Date, Dexcom (NASDAQ: DXCM) reported Q2 2023 earnings per share (EPS) of $0.30, up 130.77% year over year. Total Dexcom earnings for the quarter were $115.90 million. In the same quarter last year, Dexcom's earnings per share (EPS) was $0.13.

If you're new to stock investing, here's how to buy Dexcom stock.

What was DXCM's earnings growth in the past year?

As of Q3 2023, Dexcom's earnings has grown 55% year over year. This is 57.43 percentage points higher than the US Medical Devices industry earnings growth rate of -2.43%. Dexcom's earnings in the past year totalled $357.50 million.

What is DXCM's earnings date?

Dexcom's earnings date is Invalid Date. Add DXCM to your watchlist to be reminded of DXCM's next earnings announcement.

What was DXCM's revenue last quarter?

On Invalid Date, Dexcom (NASDAQ: DXCM) reported Q2 2023 revenue of $871.30 million up 25.15% year over year. In the same quarter last year, Dexcom's revenue was $696.20 million.

What was DXCM's revenue growth in the past year?

As of Q3 2023, Dexcom's revenue has grown 19.61% year over year. This is 13.78 percentage points higher than the US Medical Devices industry revenue growth rate of 5.82%. Dexcom's revenue in the past year totalled $3.20 billion.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.